Free Trial

Neville Rodie & Shaw Inc. Sells 12,278 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Neville Rodie & Shaw Inc. has reduced its stake in UnitedHealth Group by 45.3% in the second quarter, leaving them with 14,799 shares valued at approximately $4.6 million.
  • UnitedHealth Group's quarterly earnings missed expectations, reporting $4.08 EPS against a consensus estimate of $4.45, despite a 12.9% year-over-year revenue increase.
  • The company declared a quarterly dividend of $2.21 per share, reflecting a 2.5% yield and a dividend payout ratio of 38.30%.
  • Five stocks to consider instead of UnitedHealth Group.

Neville Rodie & Shaw Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 45.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,799 shares of the healthcare conglomerate's stock after selling 12,278 shares during the quarter. Neville Rodie & Shaw Inc.'s holdings in UnitedHealth Group were worth $4,617,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Central Pacific Bank Trust Division boosted its stake in shares of UnitedHealth Group by 3.9% in the 2nd quarter. Central Pacific Bank Trust Division now owns 3,822 shares of the healthcare conglomerate's stock valued at $1,192,000 after purchasing an additional 142 shares during the last quarter. Legacy Wealth Management LLC MS boosted its stake in UnitedHealth Group by 77.3% during the second quarter. Legacy Wealth Management LLC MS now owns 14,939 shares of the healthcare conglomerate's stock worth $4,661,000 after acquiring an additional 6,515 shares in the last quarter. Kera Capital Partners Inc. boosted its stake in UnitedHealth Group by 45.6% during the second quarter. Kera Capital Partners Inc. now owns 728 shares of the healthcare conglomerate's stock worth $227,000 after acquiring an additional 228 shares in the last quarter. Rowlandmiller & PARTNERS.ADV boosted its stake in UnitedHealth Group by 884.6% during the second quarter. Rowlandmiller & PARTNERS.ADV now owns 2,363 shares of the healthcare conglomerate's stock worth $737,000 after acquiring an additional 2,123 shares in the last quarter. Finally, Cullen Investment Group LTD. boosted its stake in UnitedHealth Group by 45.5% during the second quarter. Cullen Investment Group LTD. now owns 15,376 shares of the healthcare conglomerate's stock worth $4,797,000 after acquiring an additional 4,807 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH traded up $0.79 during trading hours on Wednesday, reaching $340.57. 3,635,260 shares of the company were exchanged, compared to its average volume of 13,011,745. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The business's 50 day simple moving average is $293.51 and its 200-day simple moving average is $367.23. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $308.44 billion, a P/E ratio of 14.71, a P/E/G ratio of 2.27 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. The business's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on UNH shares. Truist Financial increased their target price on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $358.95.

Read Our Latest Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines